LOS ANGELES -- skinbetter science, a dermatologist-recommended retinoid brand, continues to lead the evolution of the retinoid category with new clinical findings that further demonstrate the brand's commitment to advancing retinoid science, innovation and education. skinbetter also is celebrating the 10-year anniversary of its AlphaRet technology this year.
What has defined AlphaRet for a decade is its ability to deliver visible retinoid results with a high level of tolerability. According to the study, 98% of retinoid-sensitive users agreed that AlphaRet Overnight Cream can be used nightly. This demonstrates the potential for consistent use even among consumers who have historically struggled to incorporate a retinoid into their skincare routine.
Clinical findings from the 12-week clinical study on patients with retinoid intolerance showcase*:
- 98% agreed AlphaRet Overnight Cream can be used nightly
- 95% agreed skin felt smoother, firmer and comfortable
- +42% improvement in hydration at 12 weeks
- +48% improvement in skin dullness at 12 weeks
"As we celebrate our third National Retinoid Week, we're continuing our commitment to advancing the category and helping more consumers better understand how to confidently incorporate retinoids into their routines," says Geneviève Bibeau, General Manager of skinbetter science USA. "At skinbetter science, we believe consumers shouldn't have to choose between efficacy and tolerability. AlphaRet was created to challenge that compromise through advanced science that delivers prescription-strength efficacy and visible results with a high level of tolerability. National Retinoid Week allows us to bring that science to life through dermatologist-led education, expert partnerships and engaging social programming that connects consumers with credible information and helps them make more informed choices for their individual skin needs."
skinbetter partner Annie Gonzalez, MD, FAAD Board-certified Dermatologist and Founder of Glösense Dermatology & Aesthetics shares,"what impressed me most about this study wasn't the efficacy data - it was who they tested it on. These were self-identified retinoid-intolerant patients, the ones who'd already tried and failed other retinoids and even in that group, skinbetter science saw extremely high tolerability over twelve weeks. That's impressive!"
Study Details:
*A 12-week multicenter, dermatologist-led clinical study evaluated nightly use of AlphaRet Overnight Cream in participants with self-identified retinoid sensitivity and mild-to-moderate photoaging. (N=56)
